Literature DB >> 10620517

Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B).

O Cunningham1, M G Gore, T J Mantle.   

Abstract

The initial-rate kinetics of the flavin reductase reaction catalysed by biliverdin-IXbeta reductase at pH 7.5 are consistent with a rapid-equilibrium ordered mechanism, with the pyridine nucleotide binding first. NADPH binding to the free enzyme was characterized using stopped-flow fluorescence quenching, and a K(d) of 15.8 microM was calculated. Equilibrium fluorescence quenching experiments indicated a K(d) of 0.55 microM, suggesting that an enzyme-NADPH encounter complex (K(d) 15.8 microM) isomerizes to a more stable 'nucleotide-induced' conformation. The enzyme was shown to catalyse the reduction of FMN, FAD and riboflavin, with K(m) values of 52 microM, 125 microM and 53 microM, respectively. Lumichrome was shown to be a competitive inhibitor against FMN, with a K(i) of 76 microM, indicating that interactions with the isoalloxazine ring are probably sufficient for binding. During initial experiments it was observed that both the flavin reductase and biliverdin reductase activities of the enzyme exhibit a sharp optimum at pH 5 in citrate buffer. An initial-rate study indicated that the enzyme obeys a steady-state ordered mechanism in this buffer. The initial-rate kinetics in sodium acetate at pH 5 are consistent with a rapid-equilibrium ordered mechanism, indicating that citrate may directly affect the enzyme's behaviour at pH 5. Mesobiliverdin XIIIalpha, a synthetic biliverdin which binds to flavin reductase but does not act as a substrate for the enzyme, exhibits competitive kinetics with FMN (K(i) 0.59 microM) and mixed-inhibition kinetics with NADPH. This is consistent with a single pyridine nucleotide site and competition by FMN and biliverdin for a second site. Interestingly, flavin reductase/biliverdin-IXbeta reductase has also been shown to exhibit ferric reductase activity, with an apparent K(m) of 2.5 microM for the ferric iron. The ferric reductase reaction requires NAD(P)H and FMN. This activity is intriguing, as haem cleavage in the foetus produces non-alpha isomers of biliverdin and ferric iron, both of which are substrates for flavin reductase/biliverdin-IXbeta reductase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620517      PMCID: PMC1220769     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Graphical determination of the dissociation constants for two-substrate enzyme systems.

Authors:  J R FLORINI; C S VESTLING
Journal:  Biochim Biophys Acta       Date:  1957-09

2.  The photoperoxidation of unsaturated organic molecules--XV. O21Delta g quenching by bilirubin and biliverdin.

Authors:  B Stevens; R D Small
Journal:  Photochem Photobiol       Date:  1976-01       Impact factor: 3.421

3.  Fluorescence-quenching studies of the binding of bilirubin to albumin.

Authors:  R L Levine
Journal:  Clin Chem       Date:  1977-12       Impact factor: 8.327

4.  Comparison of the biliary excretion of the four isomers of bilirubin-IX in Wistar and homozygous Gunn rats.

Authors:  N Blanckaert; K P Heirwegh; Z Zaman
Journal:  Biochem J       Date:  1977-04-15       Impact factor: 3.857

5.  The green hemoproteins of bovine erythrocytes. I purification and characterization.

Authors:  L J DeFilippi; D E Hultquist
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

6.  Enzymatic oxidation of bilirubin.

Authors:  R Brodersen; P Bartels
Journal:  Eur J Biochem       Date:  1969-10

7.  The green hemoproteins of bovine erythrocytes. II. Spectral, ligand-binding, and electrochemical properties.

Authors:  L J DeFilippi; D E Hultquist
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

8.  Antioxidant activity of albumin-bound bilirubin.

Authors:  R Stocker; A N Glazer; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  NAD(P)H:flavin oxidoreductase of Escherichia coli. A ferric iron reductase participating in the generation of the free radical of ribonucleotide reductase.

Authors:  M Fontecave; R Eliasson; P Reichard
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

10.  Reduction and mobilization of iron by a NAD(P)H:flavin oxidoreductase from Escherichia coli.

Authors:  J Coves; M Fontecave
Journal:  Eur J Biochem       Date:  1993-02-01
View more
  17 in total

Review 1.  Biliverdin reductase isozymes in metabolism.

Authors:  Luke O'Brien; Peter A Hosick; Kezia John; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2015-02-25       Impact factor: 12.015

2.  Spectroscopy and photophysics of iso- and alloxazines: experimental and theoretical study.

Authors:  Ewa Sikorska; Igor V Khmelinskii; David R Worrall; Jacek Koput; Marek Sikorski
Journal:  J Fluoresc       Date:  2004-01       Impact factor: 2.217

3.  Enzymatic Activity and Thermodynamic Stability of Biliverdin IXβ Reductase Are Maintained by an Active Site Serine.

Authors:  Wen-Ting Chu; Natasha M Nesbitt; Dmitri V Gnatenko; Zongdong Li; Beibei Zhang; Markus A Seeliger; Seamus Browne; Timothy J Mantle; Wadie F Bahou; Jin Wang
Journal:  Chemistry       Date:  2017-01-11       Impact factor: 5.236

Review 4.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

5.  Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism.

Authors:  Zongdong Li; Natasha M Nesbitt; Lisa E Malone; Dimitri V Gnatenko; Song Wu; Daifeng Wang; Wei Zhu; Geoffrey D Girnun; Wadie F Bahou
Journal:  Biochem J       Date:  2018-03-29       Impact factor: 3.857

6.  Label-free quantitative protein profiling of vastus lateralis muscle during human aging.

Authors:  Laëtitia Théron; Marine Gueugneau; Cécile Coudy; Didier Viala; Astrid Bijlsma; Gillian Butler-Browne; Andrea Maier; Daniel Béchet; Christophe Chambon
Journal:  Mol Cell Proteomics       Date:  2013-11-11       Impact factor: 5.911

Review 7.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

8.  BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans.

Authors:  Song Wu; Zongdong Li; Dmitri V Gnatenko; Beibei Zhang; Lu Zhao; Lisa E Malone; Nedialka Markova; Timothy J Mantle; Natasha M Nesbitt; Wadie F Bahou
Journal:  Blood       Date:  2016-05-16       Impact factor: 22.113

9.  In silico and crystallographic studies identify key structural features of biliverdin IXβ reductase inhibitors having nanomolar potency.

Authors:  Natasha M Nesbitt; Xiliang Zheng; Zongdong Li; José A Manso; Wan-Yi Yen; Lisa E Malone; Jorge Ripoll-Rozada; Pedro José Barbosa Pereira; Timothy J Mantle; Jin Wang; Wadie F Bahou
Journal:  J Biol Chem       Date:  2018-02-27       Impact factor: 5.157

10.  Biliverdin Reductase B Dynamics Are Coupled to Coenzyme Binding.

Authors:  Natasia Paukovich; Mengjun Xue; James R Elder; Jasmina S Redzic; Ashley Blue; Hamish Pike; Brian G Miller; Todd M Pitts; David D Pollock; Kirk Hansen; Angelo D'Alessandro; Elan Zohar Eisenmesser
Journal:  J Mol Biol       Date:  2018-06-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.